Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.
INTRODUCTION:Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear. METHODS:Over 2 years, 248 healthy adults traveled by airplane...
Main Authors: | Michael F Harrison, Paul J Anderson, Jacob B Johnson, Maile Richert, Andrew D Miller, Bruce D Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4744068?pdf=render |
Similar Items
-
Anuric Acute Kidney Injury Induced by Acute Mountain Sickness Prophylaxis With Acetazolamide
by: Javier A. Neyra MD, et al.
Published: (2014-04-01) -
Acetazolamide for the treatment of acute mountain sickness
by: Luciano Tapia, et al.
Published: (2019-12-01) -
Ibuprofen versus acetazolamide for prevention of acute mountain sickness
by: Maximilian Schilling, et al.
Published: (2020-06-01) -
The Usefulness of Prophylactic Use of Acetazolamide in Subjects with Acute Mountain Sickness
by: Pin-Hsi Hung, et al.
Published: (2018) -
Significance of the proper acclimatization, use of the acetazolamide and dexamethasone in prevention of acute mountain sickness (AMS) – literature review
by: Karol Mazur, et al.
Published: (2020-02-01)